CLINICAL_TRIALS
trial_result
· 2023-10-25
Clinical Trial Update: Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients [Phase 2]
Summary
Phase 2 trial investigating selinexor with clarithromycin, pomalidomide, and dexamethasone for relapsed refractory multiple myeloma; study terminated with resul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Myeloma Multiple, Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-10-25